Chemical inhibitors of V3R 10 include a range of compounds that target various kinases implicated in its signaling pathways. Staurosporine, a potent protein kinase inhibitor, can disrupt the phosphorylation events essential for V3R 10 function. By blocking these kinases, Staurosporine can prevent the transfer of phosphate groups to V3R 10 or its associated proteins, effectively shutting down the signaling cascade. Similarly, Bisindolylmaleimide I targets protein kinase C, an enzyme potentially involved in V3R 10 activation, thus inhibiting the protein's functionality. H-89, by inhibiting protein kinase A, can also hinder the phosphorylation of V3R 10 or related proteins, disrupting its signal transduction process. LY294002 and Wortmannin, both PI3K inhibitors, can obstruct the phosphatidylinositol 3-kinase pathway, which is crucial for the activation of downstream targets that may be part of the V3R 10 signaling network.
In addition to these, PD98059 and U0126 target the MAPK/ERK pathway by inhibiting MEK, which can lead to the suppression of ERK activation, a protein that may be involved in V3R 10 signal transduction. SB203580 and SP600125, which selectively inhibit p38 MAP kinase and JNK respectively, can interfere with the signaling processes that involve V3R 10. This interference can result in the inhibition of the protein's functionality. PP2, a Src family kinase inhibitor, can prevent the phosphorylation of adaptor proteins that associate with V3R 10, resulting in a downstream blockage of signal propagation. AG490 inhibits JAK2 kinase, which is another kinase that may participate in the activation of pathways involving V3R 10. Finally, Gefitinib, by inhibiting the EGFR tyrosine kinase, can impede any cross-talk or upstream signaling that ultimately leads to the activation of V3R 10, thus serving as an inhibitor of the protein's activity. Each of these chemicals acts by interfering with specific kinases and signaling pathways that are critical for the functional activity of V3R 10, leading to its inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can inhibit protein kinases which are essential for the activation of V3R 10 signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits protein kinase C, which could be necessary for the activation process of V3R 10. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, potentially preventing activation of the PI3K-Akt pathway that V3R 10 may utilize. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is upstream of ERK activation; ERK may be involved in V3R 10 signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can prevent the phosphorylation of downstream targets of V3R 10. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase which could be implicated in the signaling cascade of V3R 10. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, potentially blocking the MAPK/ERK pathway that may influence V3R 10 activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 inhibits Src family kinases, which may phosphorylate V3R 10 or its associated adaptors. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which could be part of the signaling network involving V3R 10. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG490 inhibits JAK2 kinase, which may participate in the activation of pathways that V3R 10 is involved in. | ||||||